Hospira, Inc. (NYSE:HSP)
| CAPS Rating |
|
|---|---|
| Open | $33.81 |
| Previous Close | $34.11 |
| Daily Range | $33.65 - $34.08 |
| 52-Week Range | $26.92 - $59.20 |
| Market Cap | $5.57B |
| P/E Ratio | 15.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,447,725 |
| Average Daily Volume | 0 |
HSP
VS S&P 500 (SPY)
How do you think HSP will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HSP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HSP News and Commentary
- Medicines Co. Settles with APP - Analyst Blog – NASDAQ
- Hospira's Long, Slow Return to Health – Blogs @ The Motley Fool
- Don't Get Too Worked Up Over Hospira's Earnings – The Motley Fool
- Are These 2 Medical Device Makers Takeover Targets? – The Motley Fool
- Is Hospira's Growth for Real? – The Motley Fool
- Biosimilars: The Next Big Thing - Analyst Blog – NASDAQ
- Durect Investors Feel the Pain – The Motley Fool
- Get Paid to Keep Your Investing Resolutions: Buy Low – The Motley Fool
- Hospira Upped to Neutral - Analyst Blog – NASDAQ
- ICU Medical Extends Two Distribution Pacts With Hospira – SmartMoney
- This Just In: More Upgrades and Downgrades – The Motley Fool
- The Week's Biggest Stock Laggards – The Motley Fool
- Obama To Press FDA On Drug Shortages; Will Support Legislation – SmartMoney
- This Week's Top Stock Gainers and Laggards – The Motley Fool
- Checking the Quality of Hospira's Growth – The Motley Fool
- Hospira Shares Tanked: What You Need to Know – The Motley Fool
- Here's Why Akorn's Latest Report Might Worry You – The Motley Fool
- Reuters Survey: Investors Expect a Big Stock Market Rally in 2012 – NASDAQ
- Survey Says: Investors Expect a Big Stock Market Rally in 2012 – The Motley Fool
- Cancer Drug Shortages Delay, Stop Work On Clinical Trials – SmartMoney
RSS Headlines
Fool UK
